DNA in situ hybridization as an adjunct in tumor diagnosis
1Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.
American Journal of Clinical Pathology
|July 9, 1999
Abstract:
DNA in situ hybridization (ISH) methods, particularly fluorescence in situ hybridization, have gained broad acceptance in the clinical cytogenetic and research communities, but are used less frequently by noncytogenetic diagnostic pathology services. This review discusses tumor-related ISH, including the advantages and limitations of enzymatic detection ("insituhistochemistry"). The ISH applications are categorized with respect to diagnostic capabilities, ease of use, and cost.
Related Concept Videos
02:07FISH - Fluorescent In-situ Hybridization
Fluorescence in situ hybridization, or FISH, was developed in the early 1980s and has quickly become one of the most widely used techniques in cytogenetics. Labeled probes are used to bind complementary DNA or RNA sequences on a chromosome or in a region within a cell. Earlier, the probes could only be obtained by cloning or reverse transcription of a DNA template. Currently, the probe oligonucleotides can be synthesized synthetically. Additionally, with the advancement of optical techniques,...
02:31In-situ Hybridization
In situ hybridization (ISH) is a technique used to detect and localize specific DNA or RNA molecules in cells, tissue, or tissue sections using a labeled probe. The technique was first used in 1969 for the investigation of nucleic acids. It is currently an essential tool in scientific research and clinical settings, especially for diagnostic purposes.
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...